Publisher Correction: The molecular reach of antibodies crucially underpins their viral neutralisation capacity
Huhn A. et al, (2025), Nature Communications, 16
Engineering Genome-Free Bacterial Cells for Effective SARS-COV-2 Neutralisation.
Yin Y. et al, (2025), Microb Biotechnol, 18
The molecular reach of antibodies crucially underpins their viral neutralisation capacity
DUSHEK O., (2024), Nature Communications
Concerted deletions eliminate a neutralizing supersite in SARS-CoV-2 BA.2.87.1 spike.
Duyvesteyn HME. et al, (2024), Structure, 32, 1594 - 1602.e6
Immunogenicity of Abdala COVID-19 vaccine in Vietnamese people after primary and booster vaccinations: A prospective observational study in Vietnam.
Thanh TT. et al, (2024), Int J Infect Dis, 147
Oligomerisation-driven avidity controls SARS-CoV-2 cellular binding and inhibition
Asor R. et al, (2024), Proceedings of the National Academy of Sciences of the United States of America
AZD3152 neutralizes SARS-CoV-2 historical and contemporary variants and is protective in hamsters and well tolerated in adults.
Cai Y. et al, (2024), Sci Transl Med, 16
Improving the representativeness of UK’s national COVID-19 Infection Survey through spatio-temporal regression and post-stratification
POUWELS K. et al, (2024), Nature Communications
Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assays.
Mühlemann B. et al, (2024), Sci Transl Med, 16
The alteration of NK cells phenotypes related to the functions and dengue disease outcomes.
Taechasan N. et al, (2024), Virus Res, 345
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity.
Liu C. et al, (2024), Cell Rep Med
Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection.
Liu C. et al, (2024), Nat Commun, 15
The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86.
Zhou D. et al, (2024), Nat Commun, 15
Cooperativity and induced oligomerization control the interaction of SARS-CoV-2 with its cellular receptor and patient-derived antibodies
Asor R. et al, (2024), Biophysical Journal, 123, 313a - 313a
Emerging Enterovirus A71 Subgenogroup B5 Causing Severe Hand, Foot, and Mouth Disease, Vietnam, 2023.
Chau NVV. et al, (2024), Emerg Infect Dis, 30, 363 - 367
Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population
Jia W. et al, (2024), Nature Communications
Southeast Asia initiative to combat SARS-CoV-2 variants (SEACOVARIANTS) consortium.
Nhu LNT. et al, (2024), Wellcome open research, 9
Southeast Asia initiative to combat SARS-CoV-2 variants (SEACOVARIANTS) consortium.
Nhu LNT. et al, (2024), Wellcome Open Res, 9